Samaridou E - Search Results

1

Lipid nanoparticles for nucleic acid delivery: Current perspectives.

Samaridou E, Heyes J, Lutwyche P. Samaridou E, et al. Adv Drug Deliv Rev. 2020;154-155:37-63. doi: 10.1016/j.addr.2020.06.002. Epub 2020 Jun 8. Adv Drug Deliv Rev. 2020. PMID: 32526452 Review.

2

Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection.

Ye X, Holland R, Wood M, Pasetka C, Palmer L, Samaridou E, McClintock K, Borisevich V, Geisbert TW, Cross RW, Heyes J. Ye X, et al. Among authors: samaridou e. Mol Ther. 2023 Jan 4;31(1):269-281. doi: 10.1016/j.ymthe.2022.09.009. Epub 2022 Sep 15. Mol Ther. 2023. PMID: 36114672 Free PMC article.

3

Nose-to-brain peptide delivery - The potential of nanotechnology.

Samaridou E, Alonso MJ. Samaridou E, et al. Bioorg Med Chem. 2018 Jun 1;26(10):2888-2905. doi: 10.1016/j.bmc.2017.11.001. Epub 2017 Nov 4. Bioorg Med Chem. 2018. PMID: 29170026 Review.

4

PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.

Niu Z, Samaridou E, Jaumain E, Coëne J, Ullio G, Shrestha N, Garcia J, Durán-Lobato M, Tovar S, Santander-Ortega MJ, Lozano MV, Arroyo-Jimenez MM, Ramos-Membrive R, Peñuelas I, Mabondzo A, Préat V, Teixidó M, Giralt E, Alonso MJ. Niu Z, et al. Among authors: samaridou e. J Control Release. 2018 Apr 28;276:125-139. doi: 10.1016/j.jconrel.2018.03.004. Epub 2018 Mar 6. J Control Release. 2018. PMID: 29518466

5

Nose-to-brain delivery of enveloped RNA - cell permeating peptide nanocomplexes for the treatment of neurodegenerative diseases.

Samaridou E, Walgrave H, Salta E, Álvarez DM, Castro-López V, Loza M, Alonso MJ. Samaridou E, et al. Biomaterials. 2020 Feb;230:119657. doi: 10.1016/j.biomaterials.2019.119657. Epub 2019 Dec 6. Biomaterials. 2020. PMID: 31837821

6

Tuning the PEG surface density of the PEG-PGA enveloped Octaarginine-peptide Nanocomplexes.

Samaridou E, Kalamidas N, Santalices I, Crecente-Campo J, Alonso MJ. Samaridou E, et al. Drug Deliv Transl Res. 2020 Feb;10(1):241-258. doi: 10.1007/s13346-019-00678-3. Drug Deliv Transl Res. 2020. PMID: 31646443

7

On the synthesis of mucus permeating nanocarriers.

Bourganis V, Karamanidou T, Samaridou E, Karidi K, Kammona O, Kiparissides C. Bourganis V, et al. Among authors: samaridou e. Eur J Pharm Biopharm. 2015 Nov;97(Pt A):239-49. doi: 10.1016/j.ejpb.2015.01.021. Epub 2015 Feb 3. Eur J Pharm Biopharm. 2015. PMID: 25661586

8

Analytical techniques for the characterization of nanoparticles for mRNA delivery.

Nogueira SS, Samaridou E, Simon J, Frank S, Beck-Broichsitter M, Mehta A. Nogueira SS, et al. Among authors: samaridou e. Eur J Pharm Biopharm. 2024 May;198:114235. doi: 10.1016/j.ejpb.2024.114235. Epub 2024 Feb 23. Eur J Pharm Biopharm. 2024. PMID: 38401742 Free article. Review.

9

Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection.

Ye X, Holland R, Wood M, Pasetka C, Palmer L, Samaridou E, McClintock K, Borisevich V, Geisbert TW, Cross RW, Heyes J. Ye X, et al. Among authors: samaridou e. Mol Ther. 2023 Mar 1;31(3):911-912. doi: 10.1016/j.ymthe.2023.01.015. Epub 2023 Jan 24. Mol Ther. 2023. PMID: 36696896 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters